Literature DB >> 20586844

Antimicrobial prescribing in the USA for adult acute pharyngitis in relation to treatment guidelines.

Steven Y Hong1, Ying Taur, Michael R Jordan, Christine Wanke.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: American College of Physicians (ACP) published guidelines for the diagnosis and treatment of acute pharyngitis in adults in 2001. The objective of this study is to characterize antibiotic prescribing patterns in the USA for acute pharyngitis and evaluate concordance with the 2001 ACP pharyngitis treatment guidelines.
METHODS: Patients aged ≥18 years identified with acute pharyngitis via diagnosis codes (ICD-9 CM) were identified from data collected annually (1996-2006) by the National Center for Health Statistics and Centers for Disease Control and Prevention from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Total US office visits for acute pharyngitis were estimated. Logistic regression was performed to determine whether antibiotic prescribing was associated with the publishing of the ACP guidelines.
RESULTS: A total of 3791 office visits met study criteria. We extrapolated 78.0 million visits for acute pharyngitis from 1996 to 2006. Antibiotics were prescribed in 62.6% of cases and 7.5% of cases received ACP-recommended antibiotics. There was a significant decrease in the rate of antibiotic prescriptions from 66.5% to 59.1% after publication of ACP guidelines. Univariate analysis showed that antibiotic prescribing decreased by 27% (OR = 0.73, 95% CI 0.55-0.95, P = 0.021). Multivariate analyses confirmed this finding (OR = 0.72, 95% CI 0.56-0.94, P = 0.014). The prescribing of ACP-recommended antibiotics did not significantly change (8.5% to 6.6%, P = 0.519).
CONCLUSIONS: Publishing of ACP guidelines for the diagnosis and treatment of pharyngitis was associated with a decrease in the overall prescribing of antibiotics but not the prescribing of ACP-recommended antibiotics.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586844      PMCID: PMC2978269          DOI: 10.1111/j.1365-2753.2010.01495.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  26 in total

1.  Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.

Authors:  Miika Bergman; Solja Huikko; Pentti Huovinen; Pirkko Paakkari; Helena Seppälä
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 2.  Antiemetic guidelines: are they being used?

Authors:  Rolf Kaiser
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

3.  National campaigns to improve antibiotic use.

Authors:  Herman Goossens; Didier Guillemot; Matus Ferech; Benoit Schlemmer; Michiel Costers; Marije van Breda; Lee J Baker; Otto Cars; Peter G Davey
Journal:  Eur J Clin Pharmacol       Date:  2006-03-28       Impact factor: 2.953

4.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

5.  Evaluation and treatment of pharyngitis in primary care practice: the difference between guidelines is largely academic.

Authors:  Jeffrey A Linder; Joseph C Chan; David W Bates
Journal:  Arch Intern Med       Date:  2006-07-10

6.  Nonadherence to guidelines.

Authors:  Jihad Irani
Journal:  Arch Intern Med       Date:  2006-11-13

7.  The role of antimicrobial use in the epidemiology of resistant pneumococci: A 10-year follow up.

Authors:  Vilhjalmur A Arason; Johann A Sigurdsson; Helga Erlendsdottir; Sigurdur Gudmundsson; Karl G Kristinsson
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

8.  Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations.

Authors:  Matthew H Samore; Marc Lipsitch; Stephen C Alder; Bassam Haddadin; Greg Stoddard; Jacquelyn Williamson; Katherine Sebastian; Karen Carroll; Onder Ergonul; Yehuda Carmeli; Merle A Sande
Journal:  Am J Epidemiol       Date:  2005-11-30       Impact factor: 4.897

9.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

10.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

View more
  5 in total

Review 1.  Race/Ethnicity and overuse of care: a systematic review.

Authors:  Nancy R Kressin; Peter W Groeneveld
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

2.  PURLs: corticosteroids for a sore throat?

Authors:  Keri Bergeson; Nina Rogers; Shailendra Prasad
Journal:  J Fam Pract       Date:  2013-07       Impact factor: 0.493

3.  Prevalence of Inappropriate Antibiotic Prescribing in Primary Care Clinics within a Veterans Affairs Health Care System.

Authors:  Nathan R Shively; Deanna J Buehrle; Cornelius J Clancy; Brooke K Decker
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat.

Authors:  Jérémie F Cohen; Jean-Yves Pauchard; Nils Hjelm; Robert Cohen; Martin Chalumeau
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

5.  Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States.

Authors:  Guillermo V Sanchez; Rebecca M Roberts; Alison P Albert; Darcia D Johnson; Lauri A Hicks
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.